Thus, human RBCs constitutively produce NO under normoxic conditions via an active eNOS isoform the activity of which is compromised in patients with coronary artery disease.
Introduction
The key event in the pathogenesis of arteriosclerosis is believed to be a dysfunction of the endothelium with disruption of vascular homeostasis, predisposing blood vessels to vasoconstriction, inflammation, leukocyte adhesion, thrombosis, and proliferation of vascular smooth muscle cells. Red blood cells (RBCs) are typically considered as shuttles of respiratory gases and nutrients for tissues, less so as compartments important to vascular integrity. Patients with coronary artery disease (CAD) and concomitant anemia have a poorer prognosis following myocardial infarction, percutaneous coronary intervention, and coronary artery bypass grafting, and are more prone to developing heart failure with fatal outcomes [1] [2] [3] . Surprisingly, erythropoietin treatment fails to improve diagnosis, indicating that a compromised gas exchange/nutrient transport capacity of blood is insufficient to explain this outcome.
Nitric oxide (NO) is an essential short-lived signaling/regulatory product of a healthy endothelium that is critically important for vascular health. Decreased production and/or bioactivity of NO are a hallmark of endothelial dysfunction and have been shown to contribute to accelerated atherogenesis. In the cardiovascular system, NO is continuously produced in endothelial cells by the type III isoform of NO synthase (eNOS, NOS3; EC 1.14.13.39) 4 . In addition to endothelial cells, some circulating blood cells also contain eNOS.
It is an accepted dogma that RBCs take up and inactivate endothelium-derived NO via rapid reaction with oxyhemoglobin to form methemoglobin and nitrate, thereby limiting NO available for vasodilatation. Yet it has also been shown that RBCs not only act as "NO sinks" but synthesize, store, and transport NO metabolic products. Under hypoxic conditions in particular, it has been demonstrated that RBCs induce NO-dependent vasorelaxation. 5;6 Mechanisms of release and potential sources of NO in RBCs are still a matter of debate, but candidates include iron-nitrosyl-hemoglobin 7 , S-nitrosohemoglobin [8] [9] [10] , and nitrite. The latter may form NO either via deoxyhemoglobin 5;11 or xanthine oxidoreductase (XOR)-mediated reduction 6;12 , or via spontaneous 12 and carbonic anhydrase-facilitated disproportionation 13 .
Most of these processes show a clear oxygen-dependence, and several are favoured by low
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In contrast to hypoxia-induced NO release from RBCs, their generation of NO under normoxic conditions is less well characterized. Data from our and other laboratories have demonstrated a NOS-dependent NO production from RBCs in normoxia, suggesting RBCs may contribute to the inhibition of platelet aggregation 15;16 , the circulating pool of NO metabolites [15] [16] [17] [18] , and to overall tissue protection 17;18 . Treating RBCs with NOS inhibitors decreased accumulation of NO metabolites 16;19 and citrulline 15;18 in the supernatant.
However, Kang et al. failed to measure citrulline production in RBC lysates 20 , maybe because of loss of cellular structures or cofactors important for activity 21 .
Another recent study failed to detect increases in 15 We therefore sought to definitively identify and characterize the activity of human red cell NOS using an advanced multilevel analytical approach. Using HPLC, LC-MS/MS, flow cytometry, laser scanning microscopy and enzymatic assay together with functional studies we here demonstrate that human RBCs contain an active eNOS that gives rise to constitutive intracellular NO formation under normoxic conditions. We further show that this activity is compromised in CAD and correlates with the degree of endothelial dysfunction.
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Materials and methods

Study subjects
Blood drawn from human healthy subjects (25-33 ys) was used for biochemical characterization of human red cell eNOS. To compare NOS expression with vascular function, 10 patients with endothelial dysfunction due to coronary artery disease (CAD), as diagnosed by coronary angiography, and 9 age-matched healthy subjects were recruited from the outpatient clinic of the Department of Cardiology, Pulmonology and Angiology, Düsseldorf University Hospital. NOS activity was quantified in red cells from a randomized subset of the study population composed of 4 healthy individuals and 5 patients with CAD.
All subjects provided written informed consent before enrollment. Procedures were conducted in accordance with the Declaration of Helsinki and approved by the local ethics committee of the Heinrich-Heine University of Düsseldorf. Endothelium-dependent dilation of the brachial artery was assessed non-invasively by measurement of flow-mediated dilatation (FMD) using high-resolution ultrasound (VIVID i, GE Healthcare) 26 . FMD and endotheliumindependent dilation were expressed as a percentage change from baseline. See supplemental methods for further details. 
Comparative flow cytometric analysis of blood cells
HPLC analysis of the nitrosation products of DAF-FM
Red cell pellets were diluted 1:500 in PBS, pre-treated as described in the flow cytometry section, washed, and loaded by 30 min incubation with 10 µM DAF-FM diacetate at RT in the dark. After centrifugation at 300xg for 10 min at 4°C, pellets were incubated with HPLCgrade DMSO for 30 min at RT in the dark and spun down at 13,000xg for 10 min. The supernatants were analyzed by reversed-phase high performance liquid chromatography (HPLC) applying a method described for DAF-2 28 with some modifications, using an Agilent min-60% with a flow rate of 1 ml/min.
Identification of DAF-FM reaction products by LC-MS/MS
Mass spectra were run on an Agilent 6400 triple-quadrupole liquid chromatography mass spectrometry (LC-MS/MS) instrument operated in positive ion mode; samples were separated using a Kinetix C18 (2) 
Immunoprecipitation, gel electrophoresis and western blot analysis
Crude protein extract was obtained by lysis of RBC pellets (1 ml) with toluene 29 . EC were lysed as described 30 using rabbit anti-NOS3 antiserum (BD Bioscience) (1:1000) and HRP-conjugated goat anti-rabbit antibody (1:5000 Rockland).
Peptide sequencing by ESI-MS/MS
In-gel digestion and peptide separation was performed as described in supplemental Peptide mass accuracy for precursor ions and tolerance for fragment ions were respectively set to 2.5 and to 1 atomic mass units, allowing methionine oxidation as a possible chemical modification.
Peptide alignments
Peptide sequences were aligned with the sequences of all main NOS isoforms and eNOS splice variants using the constraint-based multiple alignment tool (COBALT) of the NCBI website (protein accession numbers NP_000611 = NOS1, nNOS; NP_000616= NOS2, iNOS; NP_000594 = NOS3, isoform 1; with splicing variants of NOS3 as NP_001153581 = NOS3, isoform 2, NP_001153582 = NOS3, isoform 3, and NP_001153583 = NOS3, isoform 4). The position of the peptides in the conserved regions were visualized using Geneious v5.4 software (Biomatters Ltd).
Determination of NOS activity
The activity of the immunoprecipitated protein was determined by measuring the rate of
as previously described 32 , in the presence or absence of the specific NOS inhibitors L-NAME
(1 mM each), or of Ca 2+ (75 µM) + calmodulin (0.04 µg/µl) (see supplemental methods for details).
Results
RBCs loaded with DAF-FM are fluorescent
To compare intracellular NO production between circulating blood cells, blood fractions enriched in leukocytes, platelets and erythrocytes were loaded with DAF-FM diacetate and analyzed by flow cytometry (Fig. 1 ). Individual cell subpopulations were identified by staining with specific surface markers and by analysis of scatter dot plots (Fig. 1A-C, panels I). Monocytes revealed the highest intracellular fluorescence intensity, followed by neutrophils, lymphocytes, RBCs, and platelets ( Fig 1D) . Whether these variations are due to differences in NO and/or reactive oxygen species (ROS) production, or dye uptake/processing remains to be investigated.
A DAF-FM-related fluorescence signal in RBCs was unexpected given the abundance of the NO scavenger oxyhemoglobin and the nitrosation scavengers glutathione and ascorbate in these cells. However, these original findings were confirmed by laser scanning microscopy ( Fig as assessed in the transmitted light channel of the laser scanning microscope and by the lack of positional changes for the RBC population in the scatter dot plot using flow cytometry. Qualitatively identical results were obtained using fluorimetry (not shown). While no changes in cell morphology or hemolysis were observed with these treatments at the concentrations used (which could have impeded flow cytometric analysis), a high NO/NOSindependent background signal was apparent using these techniques, even after correction for autofluorescence.
DAF-FM-related fluorescence in RBCs originates from reaction with NOS-derived NO
To confirm that the fluorescent signals detected by fluorimetry, laser scanning microscopy and flow cytometry were indeed due to intracellular nitrosation of DAF-FM to form DAF-FM-T, we analyzed the products of this reaction by HPLC and LC-MS/MS. A peak corresponding to DAF-FM-T was detected in loaded RBCs by reversed phase HPLC (Fig 3A) . Combined fmoles (Fig. 3F) .
RBCs contain the "classical" eNOS isoform
Having identified an intracellular constitutive NOS activity in RBCs, we next sought to isolate and identify the NOS isoform expressed in these cells. Crude hemolysates were prepared by osmotic lysis of RBC pellets with toluene/H 2 O 1:1, which preserves protein structure and activity and avoids excessive dilution. We succeeded in immunoprecipitating an eNOS-like protein employing a mouse monoclonal anti-eNOS antibody, either after enrichment of calmodulin-binding proteins by affinity chromatography (Fig. 4A, lanes 1+2 ) or directly from crude red cell lysates (Fig. 4A, lanes 3+4 ; Fig 4B) . After separation of the proteins by SDS-PAGE under reducing conditions followed by coomassie staining, a band of ~130kD was apparent in all samples (Fig 4A) . The identity of this 130kD band was confirmed by Western blotting using a polyclonal rabbit anti-human eNOS antibody (Fig. 4B) . Similar results were obtained by using the rabbit antibody for immunoprecipitation and the mouse antibody for detection, as well as by staining the membrane with a mouse monoclonal anti-eNOS To identify the immunoprecipitated protein(s), the 130kD bands of two independent coomassie-stained gels were excised (one of them shown in Fig 4C) and subjected to analysis by liquid chromatography-mass spectrometry (LC-MS/MS). Four different peptides all belonging to eNOS were identified. By alignment of the sequences of these peptides with those of the three NOS isoforms including all known splice variants of eNOS, we found that the identified peptides belong to two distinct, highly conserved regions of the reductase domain of the NOS protein (Fig. 4 D) : the FMN reductase-like region (peptides 1 and 2) and the ferredoxin reductase (FNR)-like region (peptides 3 and 4) within the FAD-binding pocket (Fig. 4D) . All four peptide sequences showed 100% pairwise identity only with the full eNOS sequence, with peptides 3 and 4 aligning within a region in the C-terminal domain that is absent in the truncated splice variants. Thus, these results show that human RBCs carry a NOS3, the "classical" eNOS isoform constitutively expressed in endothelial cells.
Isolated red cell eNOS protein is catalytically active
To verify that the erythrocytic eNOS identified is indeed active we measured the ability of the immunoprecipitated protein to catalyze the in vitro conversion of 3 H-L-arginine to 3 H-citrulline in the presence of NADPH, FAD, FMN, Ca 2+ and calmodulin. Fig. 4E depicts the results from 5 independent experiments (ANOVA p< 0.05). We found that the protein is capable of producing 9.82 fmol/min citrulline under optimal substrate/cofactor supply conditions.
Moreover, arginine to citrulline conversion was significantly inhibited by addition of the NOS inhibitor L-NAME (Fig 4E, IP 
Red cell eNOS expression and activity are compromised in patients with coronary artery disease
We explored endothelial function and erythrocytic eNOS expression levels and activity in patients with CAD, a condition associated with endothelial dysfunction, and age-matched healthy individuals. Clinical characteristics of the study population are summarized in Table   S1 . As expected, flow-mediated dilation of the brachial artery was significantly decreased in CAD patients, while maximal vasodilatation in response to GTN was not significantly different (Table S1 ). Patients with endothelial dysfunction showed a significantly lower expression of red cell eNOS compared to aged-matched healthy individuals ( Fig. 5A ; mean red cell eNOS expression was 0.519 ± 0.083 vs. 1.058 ± 0.55, unpaired T-test p < 0.0001).
Furthermore, univariate regression analysis revealed that erythrocytic eNOS expression correlated with endothelial function in humans (R 2 = 0.318 F=12.144 p=0.002) (Fig. 5A ). Red cell eNOS activity was measured in a randomized subgroup of the study population by analyzing the conversion of 14 C-Arginine into 14 C-Citrulline catalyzed by the isolated protein (Fig. 5B) . We found that red cell eNOS activity was also significantly decreased in patients with endothelial dysfunction as compared to the healthy control group (p= 0.0337, unpaired t-test) (Fig 5B) . Taken together, these results indicate that human red cell eNOS activity mirrors vascular endothelial function.
Discussion
The key findings of our study are: 1) formation of NO and related nitrosative species occurs constitutively in all subtypes of human blood cells, with cell-specific intensity differences; 2) intracellular NO formation can be visualized in RBCs using diaminofluoresceins despite the abundance of the NO scavenger oxyhemoglobin and the nitrosation scavengers glutathione 45 . Thus RBCs may also contribute to vascular homeostasis, independent of their "classical role" as transporters of oxygen, energy substrates and nutrients. Given the contribution RBCs make to the circulating NO pool and their role in hypoxic vasodilation 46 further studies are warranted to address its functional significance for the regulation of RBC function and beyond.
Origin of constitutive NO synthesis within RBCs.
Isolation, isoform identification and activity of red cell eNOS.
Previous studies have used antibodies directed against eNOS and iNOS epitopes for western blotting or immunocytochemistry to probe for the presence of a NOS in RBCs and activity assays to measure either the RBC-dependent conversion of radiolabelled arginine into citrulline or the formation of NO oxidation products. Deliconstantinos et al. isolated the protein by affinity chromatography using NADPH-binding protein affinity columns and measured L-NAME sensitive nitrite production by RBCs using a modified Griess reaction 19 .
Using immunohistochemistry, Jubelin at al. found a protein that cross-reacted with antibodies directed against calmodulin, eNOS and iNOS 25 whereas western blot analysis of RBC lysates 15;20 and membranes 6;16 confirmed the presence of a protein with eNOS epitopes. Two groups hypothesized that RBCs express a novel NOS isoform 23;25 , but no sequence confirmation analysis was provided.
The main technical hurdle in the biochemical characterization of proteins in RBCs is the presence of overwhelmingly high level of hemoglobin, which represents a formidable obstacle to purification, activity determination, immunostaining, and colorimetric/fluorimetric assay. In this study, we chose to isolate NOS from hemolysates under native conditions to permit combined structural and functional analysis. After purification of calmodulin-binding enzyme by affinity chromatography and immunoprecipitation using anti-eNOS antibodies, we
For personal use only. on January 11, 2018. by guest www.bloodjournal.org From identified a 130kD-band by SDS-PAGE, indicating that red cell NOS contains both a calmodulin binding site and eNOS-like epitopes. Similar results were obtained when immunoprecipitation was performed directly from crude RBC lysates using different antibodies. While these results strongly suggested that the 130kD band isolated from RBCs was indeed an eNOS protein, further analyses were performed to obtain peptide sequences of tryptic digests by LC-MS/MS. Obtaining the sequence of four different peptides from two independent analyses permitted unequivocal identification of the protein as the classical eNOS (NOS3) isoform. Two of the four sequenced peptides aligned with 100% homology to the C-terminal region of eNOS, which is absent in the NOS3A-C splice variants. Less homology was observed with the sequences related to nNOS (NOS1) and iNOS (NOS2).
We thus conclude that RBCs contain eNOS, the same protein that is constitutively expressed in endothelial cells. Two earlier studies suggested that RBCs also contain iNOS 20;25 . We are unable to confirm these reports as we failed to isolate any iNOS from crude human RBC lysates of healthy donors using specific anti-NOS2 antibodies for immunoprecipitation.
While a L-NNA/L-NAME-inhibitable NOS activity has been demonstrated by measuring NO metabolites or citrulline in the supernatant of intact erythrocytes 15 It was important to confirm, therefore, that the protein identified as eNOS in our study was catalytically active, L-arginine:citrulline conversion was dependent on the presence of Ca 2+ /calmodulin, and activity was inhibited by L-NAME. While we cannot exclude the additional presence of minor amounts of other NOS isoforms in RBCs it appears that the majority of NO produced in these cells is generated by an active eNOS.
Is red cell eNOS of relevance to cardiovascular disease?
Perhaps one of the most surprising results from our studies is that red cell eNOS expression and activity significantly correlate with flow-mediated dilation, a diagnostic marker of endothelial function and eNOS activity. Similarly to endothelial eNOS dysfunction, red cell
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A central challenge of any hypothesis proposing a role of RBC-derived NO in human (patho)physiology is to understand how NO formed by these cells can escape irreversible dioxygenation reaction with oxyhemoglobin, a rapid reaction known to convert NO to nitrate.
A "metabolon complex" of deoxyhemoglobin, AE/band 3, carbonic anhydrase, aquaporin and Rh-protein channels was proposed to explain nitrite protonation and may serve to facilitate the export of NO or its metabolites. 49 The localization of eNOS-immunoreactivity on the cytoplasmic side of the RBC membrane, as detected by immunogold-labelling and electron microscopy imaging 16 , supports the notion that the RBC membrane plays a central role in this process, possibly by effectively "compartmentalizing" NO production, signalling and scavenging machinery. Our results invite a rethink about the role of hemoglobin in NO biology, inasmuch as its oxygenated form is considered an NO scavenger under any condition. Several factors have been identified that explain why endothelial NO escapes scavenging by hemoglobin 8;11;46;49;50 , but those discussions did not consider the possibility that NO might be produced in RBCs themselves. The observation that NO formation can be detected in the vicinity of abundant oxyhemoglobin would seem to warrant a careful reassessment of this universally accepted paradigm.
Summary and Outlook
Only recently indices of RBC number, size, and function have emerged as independent risk factors of cardiovascular disease [1] [2] [3] . IP+L-NAME *p<0.05; # IP vs. Ca ++ /CaM T-Test p=0.0394)
